Results 171 to 180 of about 137,775 (303)

Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland

Acta Ophthalmologica, EarlyView.
Abstract Purpose Hormonal replacement therapy (HRT) in postmenopausal women appears to affect glaucoma risk, but findings are inconsistent. We aimed to explore whether the use of postmenopausal HRT plays a role in glaucoma development in Finland. Methods The main outcome variable was glaucoma incidence measured by initiation of special reimbursement ...
Sirpa Loukovaara, Jari Haukka
wiley   +1 more source

Association of TIMP2 Gene Variants With Development of Diabetic Retinopathy. [PDF]

In Vivo
Huang CT, Chien HW, Wang K, Su SC, Ting CH, Yang SF, Liao MY.   +6 more
europepmc   +1 more source

Patient‐reported outcomes and visual function after four refractive strategies in cataract surgery: A randomized controlled trial

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate patient‐reported outcome measures (PROMs) and visual function across four groups of public cataract patients: emmetropia, mini‐monovision, monovision with partial‐range of field (RoF) narrow intraocular lenses (IOLs) and patients implanted with partial‐RoF extended IOLs.
Anne Guldhammer Skov, Morten la Cour, Birgitte Moldow, Lars Holm, Therese Krarup   +4 more
wiley   +1 more source

Radiomics-Based Fundus Photography Analysis in Diabetic Retinopathy. [PDF]

Transl Vis Sci Technol
Sadeghi E, Williamson RC, Corona F, Davis E, Kozlov M, Vupparaboina KK, Bollepalli SC, Sahel JA, Chhablani J, Waxman EL.   +9 more
europepmc   +1 more source

The impact of coronary artery bypass grafting on the short‐ and long‐term development and progression of diabetic retinopathy: A Danish national matched cohort study

Acta Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) is a frequent long‐term complication of diabetes. While hemodynamic changes are known risk factors for DR, the effect of coronary artery bypass grafting (CABG) on the development of DR is poorly investigated.
Lukas Greve Maschoreck, Lonny Stokholm, Frederik Nørregaard Pedersen, Nis Andersen, Jens Andresen, Toke Bek, Sebastian Dinesen, Javad Hajari, Steffen Heegaard, Kurt Højlund, Caroline Schmidt Laugesen, Ryo Kawasaki, Sören Möller, Katja Christina Schielke, Yousif Subhi, Anne Suhr Thykjær Petersen, Jakob Grauslund   +16 more
wiley   +1 more source

Glycosylation gene-based molecular recognition model for diabetic retinopathy. [PDF]

Front Med (Lausanne)
Wu Q, Ma PP.
europepmc   +1 more source

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car, Isabelle Huys, Steven Simoens, Arnold G. Vulto   +3 more
wiley   +1 more source

Regulation of Mitochondrial Biogenesis in Diabetic Retinopathy. [PDF]

Cells
Kumar J, Kowluru RA.
europepmc   +1 more source

Adult‐onset Coats disease: A systematic review and meta‐analysis of imaging biomarkers and targeted therapies

Acta Ophthalmologica, EarlyView.
Abstract Coats disease diagnosed in adulthood is a rare idiopathic retinal telangiectatic vasculopathy that may differ in phenotype from childhood‐diagnosed cases. This systematic review synthesizes current evidence to characterize its clinical spectrum, imaging features, treatment outcomes and underlying mechanisms, with a focus on immunovascular ...
Catarina Francisco, Nisa Silva, Camiel J. F. Boon   +2 more
wiley   +1 more source

Worsening of diabetic retinopathy with initiation of an automated insulin delivery system. [PDF]

Am J Ophthalmol Case Rep
Nesemann JM, Dove D, Brodie FL, Masharani U.   +3 more
europepmc   +1 more source